Cobra Biologics, an international CDMO of biologics and pharmaceuticals, and Tecrea, a cell delivery biotechnology company, have been awarded a 15-month collaborative grant of £112,291 ($166,000) by the UK’s innovation agency, Innovate UK, for the development of a scalable Adeno Associated Virus (AAV) production bioprocess. The grant is awarded under Innovate UK’s Technology Inspired Innovation competition, which aims to stimulate innovation within biosciences, identified by UK government as one...